
    
      Patients are admitted to a multidisciplinary consultation (neurologist, PMK) to validate the
      indication of treatment with IGIV. Realization of a pre-therapeutic evaluation in the
      department of MPR on the criteria of judgment, then the patient is admitted in a service of
      neurology to benefit from the cure of IGIV. The patient is then re-admitted to a PMR service
      for post-treatment evaluation.

      Collection of data retrospectively.
    
  